Subscribe today!
Research Areas
Research Areas
Neuroscience
Cancer Research
Immunology
Infectious Disease & Vaccines
Hematology
Ophthalmology
Rare & Genetic Diseases
Dermatology
Internal Medicine
Metabolic Disease
Tools & Techniques
Regulatory & Industry
All Research Areas
News
Discovery Insider
Content
Content
Webinars
eBooks
Infographics
Videos
Articles
Industry Perspectives
Compendiums
Whitepapers
Application Notes
Magazine
All Content
Research Areas
Research Areas
Neuroscience
Cancer Research
Immunology
Infectious Disease & Vaccines
Hematology
Ophthalmology
Rare & Genetic Diseases
Dermatology
Internal Medicine
Metabolic Disease
Tools & Techniques
Regulatory & Industry
All Research Areas
News
Discovery Insider
Content
Content
Webinars
eBooks
Infographics
Videos
Articles
Industry Perspectives
Compendiums
Whitepapers
Application Notes
Magazine
All Content
Subscribe!
Subscribe Today!
Home
/
Research Areas
Research Areas
| 2 min read
By
Jeffrey Bouley
Enzyme market penetration
Millipore’s global reach will help get JPT’s enzyme line worldwide customers
Articles
| 2 min read
By
Jeffrey Bouley
Making hepatitis C an A-list concern
Articles
| 3 min read
By
Randall C Willis
Q&A: Sara Hall, CEO, Tacere Therapeutics
Articles
| 2 min read
By
Chris Anderson
Cogenics, Algynomics team up on pain panel
Genetic markers to allow clients to examine the genetic basis or underpinnings of human pain.
Articles
| 2 min read
By
Jeffrey Bouley
Tag-teaming tuberculosis
Cumbre and TB Alliance announce partnership to develop new TB agents
Articles
| 2 min read
Rx3 recieves two NIH grants
Company wants to fight drug-resistant organisms.
Articles
| 2 min read
By
Jeffrey Bouley
Yale, NFCR launch cancer drug research center
Five-year, $750,000 grant to develop new beta-peptide inhibitors.
Articles
| 2 min read
By
Chris Anderson
NGI co-develops R&D office, incubator with U. Iowa
Plans to build a new 80,000-sq.ft research center and business incubator.
Articles
| 2 min read
Microarrays have big future in store
SNP market at about $400 million; in next 5 years to $1 billion.
Articles
| 2 min read
Gilead Sciences to acquire Myogen for $2.5 billion
Myogen will become a wholly-owned subsidiary of Gilead.
Articles
Page 1136 of 1200 - 11998 Total Items
1132
1133
1134
1135
1136
1137
1138
1139
1140
Popular Topics
Infectious Disease & Vaccines
Internal Medicine
Cancer
Tools & Techniques
Immunology
Hematology
Multimedia
By
Thermo Fisher Scientific
Skip RNA purification for faster RT-qPCR workflows
Explore how direct cell lysis can reduce sample preparation steps and support efficient gene expression analysis by RT-qPCR.
Webinars
By
Drug Discovery News
Where drug discovery goes next
Expert insights on the ideas and innovations reshaping the field.
Ebooks
By
Pelago Bioscience
Mapping degrader activity and selectivity in intact cells
Explore how cereblon allostery and cellular target engagement profiling can reveal the mechanisms and selectivity underlying degrader activity.
Webinars
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe
Sponsored
Skip RNA purification for faster RT-qPCR workflows
Explore how direct cell lysis can reduce sample preparation steps and support efficient gene expression analysis by RT-qPCR.
Webinars
How to choose the right fluorochromes for complex flow cytometry panels
Compare fluorochromes based on resolution, spillover, antigen expression, and other factors that can affect panel performance.
Whitepaper
Technology Guide: High-content analysis in modern drug discovery
As researchers embrace more complex cellular models, high-content analysis brings new opportunities and challenges to drug discovery.
Technology Guides